Meet us at

  • Deutsche Biotechnologietage 2020 on 27th-28th May in Wiesbaden, Germany:
    Due to the current situation the organizer of the Deutsche Biotechnologietage has cancelled the event.

Hopefully we can meet in near future at other events in person.
At the moment the current Covid-19 pandemic forced us to meet our customers via Web-conferences.
Please do not hesitate to contact us:

Tel: +49 89 800 650 0
Fax: +49 89 800 650 555
bd@cro-sss.de

News / 01.04.2020
Successfully mastering data explosion in clinical projects
SSS recent publication in Pharmind gives an overview how to handle the increasing amount of data in clinical studies with Clinical Trial Management Systems (CTMS). ###Pharmind: 31 March, 2020; pp. 331-337 "Datenflut in klinischen Studien beherrschen" Within the article we describe how low-code programming could help to create an own CTMS with moderate resources. Highly flexibility allows to align the system with companies’ processes, to add new applications or to adapt to individual needs of client projects. SSS has followed this route and reports about their experience.
read more
News / 19.06.2019
Restructuring of Romanian health authority breathes new life into clinical trials in Romania
Over the past years pharmaceutical companies had to face unpredictable and increasingly long response times for clinical trial approvals in Romania. Now, the NAMMD published very encouraging figures showing a significant increase in clinical trial approvals in 2019 thanks to an ongoing restructuring process that NAMMD started in 2018.
read more
News / 01.04.2019
New recommendation of the Bundesärztekammer strengthens practical aspects in the qualification of investigators
From 01. April 2019 on the recommendations for the assessment of the investigator’s qualifications in clinical studies published by the `Arbeitskreis Ethikkommissionen´ has been replaced by a new version which has been passed by the Bundesärztekammer on 13./14. December 2018. The new recommendation comes along with some important changes, especially clinical expertise is more recognized now. In the future
read more
Events / 25.10 - 26.10.2018
SSS presented on TÜV SÜD conference about challenges in clinical investigations due to the new medical device regulation (MDR)
On this year's TÜV SÜD medical device forum taking place in Hamburg´s historic "Kaffeebörse" SSS were invited to share their view in a presentation about the conduct of clinical investigations under the new medical device regulation (MDR). Dr. Max Mösmang, Senior Project Manager at SSS International Clinical Research, pointed out that the regulation which will come into force on 26. May 2020 will demand increased clinical evidence about safety and benefits to be demonstrated by manufacturers of medical devices.
read more
News / 14.06.2018
25th anniversary of SSS: Well equipped for the digital future
The medium-sized contract research institute SSS Clinical Research celebrates its 25th anniversary. SSS benefits greatly from its IT-driven approach and is therefore well prepared for the digital future of the industry. Germering near Munich, 14.06.2018. SSS International Clinical Research GmbH (SSS), contract research institute for clinical studies (CRO), celebrated its 25th anniversary at Schloss Dachau. Initially started as an auditing service for the quality assurance of clinical research, the company has now established itself as a competent partner for international study projects for pharmaceuticals, biotech and medical technology companies.
read more
Events / 18.04 - 19.04.2018
SSS at "Deutsche Biotechnologietage 2018"
This years "Deutschen Biotechnologietage" have been taken place for the eighth time. More than 900 participants from start-ups, universities, companies, funding bodies and public institutions met on the 18th and 19th of April in Berlin to discuss newest trends in the field. Highlight of this year’s event have been an address of the new German Mister of Economics, Peter Altmaier.
read more
News / 20.11.2017
Pharmacovigilance: the countdown is on
As early as 2010, the EU Regulation No. 1235/2010 kicked off a reorientation in drug safety. The aim was and is to create more transparency with standardized approval procedures and to provide faster and better information about drug safety. This November, the transitional period for the new version of the pan-European database ends.
read more
News / 03.08.2017
More manpower for research
From July 2017, Dr. Lars Behrend (45) will fill the role of COO, covering the key areas of financial management, controlling and business development. Lars Behrend holds a diploma in biology and a PhD in cancer research. He has 15 years work experience in management and consulting within the medical sector, biotechnology and cleantech areas.
read more
© 2020 SSS International Clinical Research